Safety of pediatric HIV elimination: the growing population of HIV- and antiretroviral-exposed but uninfected infants

Lynne M Mofenson; D Heather Watts

doi:10.1371/journal.pmed.1001636

Safety of pediatric HIV elimination: the growing population of HIV- and antiretroviral-exposed but uninfected infants

PLoS Med. 2014 Apr 29;11(4):e1001636. doi: 10.1371/journal.pmed.1001636. eCollection 2014 Apr.

Authors

Lynne M Mofenson¹, D Heather Watts²

Affiliations

¹ Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland, United States of America.
² Office of the Global AIDS Coordinator, US Department of State, Washington (D.C.), United States of America.

Abstract

Lynne Mofenson and Heather Watts discuss the context and implications of the study by J. Sibuide and colleagues, which provides a detailed analysis of birth defects in infants with in utero antiretroviral drug exposure in the French Perinatal Cohort. Please see later in the article for the Editors' Summary.

Publication types

Comment

MeSH terms

Anti-HIV Agents / adverse effects*
Anti-HIV Agents / therapeutic use*
Congenital Abnormalities / etiology*
Female
HIV Infections / drug therapy*
Heart Defects, Congenital / chemically induced*
Humans
Pregnancy
Prenatal Exposure Delayed Effects / epidemiology*

Substances

Anti-HIV Agents

Grants and funding

No funding was received for this article.